Leveraging light scattering techniques for enhanced biotherapeutic characterization and development
Prof. Dr. Hristo L. Svilenov, Professor of Biopharmaceutical Technology at Ghent University, and Dr. Lorenzo Gentiluomo, Senior Sales Account Manager at Waters/Wyatt Technology, will present several case studies demonstrating the use of various light scattering techniques for the advanced characterization of biopharmaceutical samples. They will focus on dynamic light scattering (DLS), size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS) and real-time multi-angle light scattering (RT-MALS).
Key learning objectives
- Learn the basics of light scattering techniques
- Discover how to effectively distinguish between different light scattering methods, including DLS, SLS, SEC-MALS and RT-MALS
- Understand how different light scattering can be used to characterize therapeutic proteins
Who should attend?
Scientists interested in the analytical characterization of biopharmaceuticals using light scattering techniques.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Dr. Hristo L. Svilenov is an Associate Professor in Biopharmaceutical Technology at Ghent University. His research interests are in the development, formulation and manufacturing aspects of biotherapeutics. Previously, he was a postdoctoral researcher funded by a Peter and Traudl Engelhorn Fellowship at the TU Munich. He completed his PhD supported by a Marie Sklodowska-Curie Fellowship at the Ludwig Maximilian University of Munich.
Dr. Lorenzo Gentiluomo has extensive experience in drug product development. He has successfully managed the development of 26 biological drug candidates, including 3 BLA projects, during his tenure at Coriolis and Lonza. He now serves as Senior Account Sales Manager for Wyatt Technology, where he applies his technical expertise to support and expand the use of advanced analytical solutions in the biopharmaceutical industry.
Moderator
